Detalles de la búsqueda
1.
Short-Term Cannabidiol with Δ-9-Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial.
Mov Disord
; 2024 Mar 15.
Artículo
Inglés
| MEDLINE | ID: mdl-38487964
2.
Cognitive Safety Data from a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase IIb Study of the Effects of a Cannabidiol and Δ9-Tetrahydrocannabinol Drug on Parkinson's Disease-Related Motor Symptoms.
Mov Disord
; 38(7): 1341-1346, 2023 07.
Artículo
Inglés
| MEDLINE | ID: mdl-37212386
3.
Reply to: Cognitive Safety of Cannabis Products in Parkinson's Disease: Need for Solid Scientific Evidence to Guide Clinicians and Patients Currently on Shaky Grounds.
Mov Disord
; 39(1): 222-223, 2024 Jan.
Artículo
Inglés
| MEDLINE | ID: mdl-38294047
4.
Higher Risk, Higher Reward? Self-Reported Effects of Real-World Cannabis Use in Parkinson's Disease.
Mov Disord Clin Pract
; 9(3): 340-350, 2022 Apr.
Artículo
Inglés
| MEDLINE | ID: mdl-35392299
5.
The APPCN multisite didactic initiative: Development, benefits, and challenges.
Clin Neuropsychol
; 35(1): 115-132, 2021 01.
Artículo
Inglés
| MEDLINE | ID: mdl-32615854
6.
Comparing two models of performance validity assessment in patients with Parkinson's disease who are candidates for deep brain stimulation surgery.
Appl Neuropsychol Adult
; 27(1): 9-21, 2020.
Artículo
Inglés
| MEDLINE | ID: mdl-30183361
7.
Are Established Embedded Performance Validity Test Cut-Offs Generalizable to Patients With Multiple Sclerosis?
Arch Clin Neuropsychol
; 35(5): 511-516, 2020 Jul 24.
Artículo
Inglés
| MEDLINE | ID: mdl-32186676
8.
The impact of cannabis use on intracarotid amobarbital testing.
Epilepsy Behav Rep
; 12: 100328, 2019.
Artículo
Inglés
| MEDLINE | ID: mdl-31497755
9.
Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.
Mult Scler Relat Disord
; 27: 383-390, 2019 Jan.
Artículo
Inglés
| MEDLINE | ID: mdl-30502644
Resultados
1 -
9
de 9
1
Próxima >
>>